Showing results (161-170 of 1,059) with videos related to

Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Discontinuation and nonpublication of interventional clinical trials conducted in patients with mild cognitive impairment and Alzheimer's diseaseTaygan Yilmaz, Roos J Jutten, Cláudia Y Santos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research settingGwendolien Vanderschaeghe, Jolien Schaeverbeke, Rose Bruffaerts, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2018
Neuroimaging and neuropsychological assessment of freezing of gait in Parkinson's diseaseBrent Bluett, Sarah Banks, Dietmar Cordes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 10, 2018
Case-finding in clinical practice: An appropriate strategy for dementia identification?Janice M Ranson, Elżbieta Kuźma, William Hamilton, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 10, 2018
Patient perspectives of the experience of a computerized cognitive assessment in a clinical settingJulie M Robillard, Jen-Ai Lai, Julia M Wu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 24, 2017
Dissociation of Down syndrome and Alzheimer's disease effects with imagingDawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairmentGuoqiao Wang, Richard E Kennedy, Gary R Cutter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementiaLaura M Gault, Craig W Ritchie, Weining Z Robieson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trialHee Jin Kim, Sang Won Seo, Jong Wook Chang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's diseaseGareth Maher-Edwards, Jeni De'Ath, Carly Barnett, et al.
Pageof 106